Cargando…

Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV

Dipeptidyl peptidase IV (DPP IV) is a surface glycoprotein that can degrade glucagon like pepetide-1 (GLP-1) by decreasing blood sugar. Herbal medicines for diabetic therapy are widely used with acceptable efficacy but unsatisfied in advances. DPP IV was chosen as a template to employ molecular dock...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Po-Kai, Lin, Shian-Ren, Chang, Chia-Hsiang, Tsai, May-Jwan, Lee, Der-Nan, Weng, Ching-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821704/ https://www.ncbi.nlm.nih.gov/pubmed/31666589 http://dx.doi.org/10.1038/s41598-019-52088-7

Ejemplares similares

The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo
por: Lin, Shian-Ren, et al.
Publicado: (2019)

Polyalthia Clerodane Diterpene Potentiates Hypoglycemia via Inhibition of Dipeptidyl Peptidase 4
por: Huang, Po-Kai, et al.
Publicado: (2019)

Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice
por: Huang, Po-Kai, et al.
Publicado: (2017)

Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management
por: Fan, Junfeng, et al.
Publicado: (2013)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010)

Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase
por: Riyaphan, Jirawat, et al.
Publicado: (2018)

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010)

Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)

Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020)

Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)

Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor
por: Rozano, Lina, et al.
Publicado: (2017)

Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
por: Lin, Shian‐Ren, et al.
Publicado: (2019)

Potential Role of Dipeptidyl Peptidase IV in the Pathophysiology of Heart Failure
por: Salles, Thiago A., et al.
Publicado: (2015)

Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis
por: Larrinaga, Gorka, et al.
Publicado: (2015)

Suppression of neuroblastoma growth by dipeptidyl peptidase IV: Relevance of chemokine regulation and caspase activation
por: Tristram Arscott, W., et al.
Publicado: (2008)

Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: Dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme)()
por: Juillerat-Jeanneret, Lucienne, et al.
Publicado: (1997)

Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents
por: Mohammad, Badrud Duza, et al.
Publicado: (2022)

Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
por: Nojima, Hiroyuki, et al.
Publicado: (2016)

Constituents of Coreopsis lanceolata Flower and Their Dipeptidyl Peptidase IV Inhibitory Effects
por: Kim, Bo-Ram, et al.
Publicado: (2020)

CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions
por: Pan, Kelsey, et al.
Publicado: (2021)

Assessment of serum dipeptidyl peptidase-IV levels in autoimmune thyroid disease
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
por: Rohani, et al.
Publicado: (2023)

Structural Similarities, in Relation with the Cross-Reactivity, of Hymenoptera Allergenic Dipeptidyl Peptidases IV—An Overall Comparison Including a New Dipeptidyl Peptidase IV Sequence from Vespa velutina
por: Monsalve, Rafael I., et al.
Publicado: (2023)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
por: Wesley, Umadevi V., et al.
Publicado: (1999)

Dipeptidyl Peptidase IV and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) study
por: Luft, Vivian C., et al.
Publicado: (2010)

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
por: Joo, Kwon Wook, et al.
Publicado: (2013)

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats
por: Neidert, Leslie E., et al.
Publicado: (2018)

Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review
por: Liu, Rui, et al.
Publicado: (2019)

The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy
por: Zheng, Zhicheng, et al.
Publicado: (2021)

Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis
por: Chalichem, Nehru Sai Suresh, et al.
Publicado: (2021)

Identification and Characterization of Dipeptidyl Peptidase-IV Inhibitory Peptides from Oat Proteins
por: Wang, Wei, et al.
Publicado: (2022)

Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26
por: Fletcher, Mary A., et al.
Publicado: (2010)

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
por: Suman, Rajesh Kumar, et al.
Publicado: (2016)

Mechanism of Action of Natural Dipeptidyl Peptidase-IV Inhibitors (Berberine and Mangiferin) in Experimentally Induced Diabetes with Metabolic Syndrome
por: Suman, Rajesh Kumar, et al.
Publicado: (2023)

Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate
por: Liu, Rui, et al.
Publicado: (2017)

Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
por: Ługowska, Agnieszka, et al.
Publicado: (2021)

Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis?
por: Sedo, Aleksi, et al.
Publicado: (2005)

Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia
por: Röhnert, Peter, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kpn7hippcki5ovsj6al5lub3a4